Rossby Financial’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$32.1K Buy
250
+150
+150% +$18.7K 0.01% 874
2025
Q4
$12.2K Hold
100
﹤0.01% 870
2025
Q3
$10.1K Hold
100
﹤0.01% 853
2025
Q2
$8.29K Buy
+100
New +$7.98K ﹤0.01% 824

Other funds holding XBI

Rossby Financial's XBI Position: Q1 2026 in Review

Rossby Financial increased its State Street SPDR S&P Biotech ETF (XBI) stake by 150% in Q1 2026, buying an estimated $18.7K and bringing the position to 250 shares worth $32.1K. The position accounts for 0.01% of the portfolio, ranked #874.

Rossby Financial first reported a position in XBI in Q2 2025 and has held it in 4 quarters since. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

  • Rossby Financial held 250 shares of State Street SPDR S&P Biotech ETF worth $32.1K as of Q1 2026.
  • Rossby Financial bought 150 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $18.7K.
  • State Street SPDR S&P Biotech ETF made up 0.01% of Rossby Financial's portfolio in Q1 2026, its #874 holding.
  • Rossby Financial first reported a position in State Street SPDR S&P Biotech ETF in Q2 2025 and has held it in 4 quarters since.
  • 813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Rossby Financial's 13F filing for Q1 2026, filed 11 May 2026.